Aytu Biopharma(AYTU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aciphex | Rabeprazole | 2013-03-26 | ||
| Karbinal | Carbinoxamine | 2013-03-28 | 2027-2029 | |
| Metadate | Methylphenidate | 2001-04-03 | 2024-2038 | |
| Prostascint | Capromab pendetide | 1996-10-28 | — | |
| Zolpimist | Zolpidem | 2008-12-19 | 2025-2032 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use